Friday, April 4, 2014

Research Expo Highlights: Injectable Hydrogel for Cardiac Repair




Bioengineering professor Karen Christman's new injectable hydrogel, which is designed to repair damaged cardiac tissue following a heart attack, has been licensed to San Diego-based startup Ventrix, Inc, which is planning the first human clinical trials of the technology. Christman is a co-founder of Ventrix.

In a 2013 study published in Science Translational Medicine, Christman reported the semi-solid, porous gel encourages cells to repopulate areas of damaged cardiac tissue and to preserve heart function. The hydrogel forms a scaffold to repair the tissue and increases cardiac muscle.

You can learn more about this technology at  Research Expo on April 17, where Christman is one of six faculty speakers. In the meantime, watch our video report above. Wang, an M.D./Ph.D. student in bioengineering, will present a poster explaining her research on how the hydrogel works to rebuild tissue in damaged hearts.

2. GENE EXPRESSION CHANGES DUE TO MYOCARDIAL MATRIX INJECTION INTO INFARCTED HEART

Student: Jean Wang
Professor: Karen L. Christman
Industry Application Areas: Life Sciences/Medical Devices & Instruments



1 comment:

  1. this is good post...

    i like this...

    please can you visit here..

    http://bantalsilikon01.blogspot.com/
    http://bantalsilikon01.blogdetik.com/
    http://bantalkekabumurah.blogspot.com/
    http://bumbupecel1.blogspot.com/
    http://bantalgood.blogspot.com/
    http://bantalsilikonmalang1.blogspot.com/
    http://bantalsilikonmurah.blogspot.com/

    http://marinirseo.blogspot.com/
    http://marinirseo.blogspot.com/
    http://marinirseo.blogspot.com/


    tengs very much...

    ReplyDelete